Signal active
Organization
Contact Information
Overview
SoniVie is developing an advanced denervation solution to treat pulmonary hypertension.
About
Health Care, Medical, Health Diagnostics
2014
11-50
Headquarters locations
Rosh Ha'ayin, HaMerkaz, Israel, Asia
Social
Profile Resume
SoniVie headquartered in Asia, operates in the Health Care, Medical, Health Diagnostics sector. The company focuses on Health Care and has secured $2.3B in funding across 36 round(s). With a team of 11-50 employees, SoniVie is actively contributing to advancements in Health Care. Their latest funding round, Seed Round - SoniVie, raised $2.5M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
3
1
0
$62.6M
Details
2
SoniVie has raised a total of $62.6M in funding over 2 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2023 | Late Stage Venture | 60.0M | ||
2015 | Seed | 2.5M |
Investors
SoniVie is funded by 12 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
SoniVie | - | FUNDING ROUND - SoniVie | 150.0K |
HeartX | - | FUNDING ROUND - HeartX | 150.0K |
SoniVie | - | FUNDING ROUND - SoniVie | 2.5M |
Accelmed | - | FUNDING ROUND - Accelmed | 2.5M |
Recent Activity
News
Jan 31, 2024
MassDevice - SoniVie completes enrollment in ultrasound renal denervation trial
Funding Round
Jan 09, 2023
SoniVie raised $60000000 on 2023-01-09 in Series C
Funding Round
Oct 18, 2021
SoniVie raised $150000 on 2021-10-18 in Venture Round
Funding Round
Nov 02, 2015
SoniVie raised $2500000 on 2015-11-02 in Seed Round